MiR-21 is a bona-fide “oncomir” and one of the most widely studied miRs due to its dramatic upregulation in many cancers, ability to target the tumor suppressor PTEN and thereby reducing tumor susceptibility to TKIs77, as well as its regulated expression in hypertrophic heart disease models.116. Here, PTEN is linked to neoplasm.